Description
Dapagliflozin and Metformin (Extended Release) Tablets is a combination antidiabetic medication containing Dapagliflozin and Metformin in an extended-release (ER) formulation. It is used to improve blood glucose control in adults with Type 2 Diabetes. Dapagliflozin helps remove excess glucose through urine by inhibiting SGLT2 in the kidneys, while Metformin reduces glucose production in the liver and enhances insulin sensitivity. Together, they provide effective and sustained glycemic control when combined with diet, exercise, and lifestyle modifications.
Dosage
Use as directed by the physician.
Indications
Management of Type 2 Diabetes Mellitus in adults
Improvement of glycemic control alongside diet and exercise
Patients requiring combination therapy with Dapagliflozin and Metformin
Long-term diabetes management under medical supervision
Find answers to the most common questions about our services.